Current Issue

View Larger Image

Past Issues Free Subscriptions
Sponsored
Keywords



Search Results - HIV/AIDS
 More »

  • Multitasking Multiplex Assays
    Luminex microspheres pass through a red laser or LED, which excites the internal dyes to distinguish the microsphere set. Then a green laser or LED, which excites the fluorescent ...
    10-15-2013
  • Deciphering RNA Secondary Structure
    RNAs play an integral part in all kingdoms of life and mediate critical processes from gene regulation to genomic maintenance and protein synthesis. RNAs also have an amazing ...
    10-15-2013
  • Growing and Preparing Adult Stem Cells
    Closed hoods with integrated incubation chambers are a key design feature in the Xvivio system. According to BioSpherix, incubators open only into aseptic space, and contamination ...
    10-15-2013
  • HIV Researchers Seek a Potential Cure
    HIV research has reached the point that a cure may be possible. "HIV is a complicated disease, and it's very encouraging to see advancements," says Elizabeth Wolffe, Ph.D., Sangamo ...
    10-1-2013
  • Advertorial: Advanced BioScience Laboratories (ABL)
    Groundbreaking Solutions in Biomedical Research and Manufacturing ABL is a contract research and manufacturing service provider, specializing in the development of vaccines and ...
    10-1-2013
  • NYC Institutions Launch Drug Development Institute, Partner with...
    Three top-tier New York City research powerhouses have launched a research institute created to translate early-stage research into quicker clinical development of new drugs and ...
    10-1-2013
  • SBIR Awards Etubics $1.5M to Manufacture Breast Cancer Immunotherapy
    Etubics has received an approximately $1.5 million contract from the Small Business Innovation Research Development Center of the National Cancer Institute to manufacture its ...
    9-27-2013
  • Nanoparticles Show Promise for Vaccine Delivery to Lungs
    Researchers at MIT say they have developed a novel type of nanoparticle that protects a vaccine long enough to generate a strong immune response both in the lungs and in mucosal ...
    9-26-2013
  • PATH Evaluates Janssen's Rilpivirine as HIV Infection Prophylactic
    Janssen R&D Ireland has signed a license agreement with PATH to develop an injectable form of rilpivirine as a potential pre-exposure prophylaxis (PrEP) against HIV infection. It ...
    9-25-2013
  • Receptor Structure Sheds Light on How HIV Infects Cells
    The crystallographic determination of the CCR5 receptor has been achieved, providing insights into its allosteric inhibition by Maraviroc, an HIV drug. The CCR5 receptor, which is ...
    9-12-2013
  • Turning HIV from Latent into Active Form to Treat It
    ... eradication of HIV/AIDS," said Dr. Wender, adding that his team has synthesized over 100 analogs of the compound. "When tested in various assays related to HIV/AIDS eradication, ...
    9-10-2013
  • Scientists Hope to Prevent AIDS-Like Foamy Virus Outbreak
    An international team of researchers reports that some people in Bangladesh are concurrently infected with multiple strains of simian foamy virus (SFV), including strains from more ...
    9-4-2013
  • AAV Vectors for Infectious Diseases
    University of Pennsylvania Gene Therapy Team Finds Applications in HIV, Flu, and Biothreats The failure of the adenovirus Ad5 vaccine in the STEP study, halted in 2007, sparked ...
    9-1-2013
  • Purging Protein Profiling Problems
    Early cancer biomarkers identified from homogeneous cell populations procured from frozen tissues using i-LCM and LC-MS/MS. [Lubman Research Lab, University of MIchigan] ...
    9-1-2013
  • Biopharmas Drive Antibiotic Development
    As the incidence of antibiotic resistance continues to grow, a number of small to medium-sized biofirms are focusing on developing new products to treat this global health problem. ...
    9-1-2013
  • More »

    Journal Articles

  • HIV Type 2 Primary Isolates Induce a Lower Degree of Apoptosis...
    Ana Machuca, Linna Ding, Rolf Taffs, Sherwin Lee, Owen Wood, Jinjie Hu, Indira Hewlett
    AIDS Research and Human Retroviruses
    HIV Type 2 Primary Isolates Induce a Lower Degree of Apoptosis " in Vitro " Compared with HIV Type 1 Primary Isolates AIDS Research and Human Retroviruses To determine whether ...
  • HIV-Specific Cytotoxic T Lymphocytes, HLA-A11, and Chemokine...
    Busarawan Sriwanthana, Thomas Hodge, Timothy D. Mastro, Charlene S. Dezzutti, Kyle Bond, Henry A.F. Stephens, Leondios G. Kostrikis, Khanchit Limpakarnjanarat, Nancy L. Young, Shoukat H. Qari, Renu B. Lal, Dasnayanee Chandanayingyong, Janet M. McNicholl
    AIDS Research and Human Retroviruses
    HIV-Specific Cytotoxic T Lymphocytes, HLA-A11, and Chemokine-Related Factors May Act Synergistically to Determine HIV Resistance in CCR5 Δ32-Negative Female Sex Workers in Chiang ...
  • HIV-Specific Health Care Utilization and Mortality among Tuberculosis...
    L. Beth Gadkowski, Carol D. Hamilton, Myra Allen, Ellen R. Fortenberry, Julie Luffman, Elizabeth Zeringue, Jason E. Stout
    AIDS Patient Care and STDs
    HIV-Specific Health Care Utilization and Mortality among Tuberculosis/HIV Coinfected Persons AIDS Patient Care and STDs Abstract Persons coinfected with tuberculosis (TB) and HIV ...
  • HIV-Related Knowledge, Attitudes, Perceived Benefits, and Risks...
    Alexandra Rogers, Anand Meundi, Ambikadevi Amma, Aruna Rao, Prasanna Shetty, Jubin Antony, Divya Sebastian, Padma Shetty, Avinash K. Shetty
    AIDS Patient Care and STDs
    Of the total of 202 women surveyed, 189 women (94%) had heard of HIV/AIDS and 60% of them ... and addressing stigma and discriminatory attitudes toward people living with HIV/AIDS.

GEN Webinars

View »

GEN Web Briefs

View »

GEN Poll

More » Poll Results » Archive »

Balancing Family and Career for Women Ph.D.s

Which changes made to academic culture are most likely to encourage women researchers to stay?

Suggest a Poll